{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:58:39Z","timestamp":1784743119952,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014101","name":"Novavax Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003646","name":"National Health Insurance Service","doi-asserted-by":"publisher","award":["KDCA-NHIS-2023-1-494"],"award-info":[{"award-number":["KDCA-NHIS-2023-1-494"]}],"id":[{"id":"10.13039\/501100003646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127496","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T03:23:27Z","timestamp":1752809007000},"page":"127496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Real-world effectiveness of NVX-CoV2373 and BNT162b2 mRNA COVID-19 vaccination in South Korea"],"prefix":"10.1016","volume":"62","author":[{"given":"Eunseon","family":"Gwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ah","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyuwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdenetuya","family":"Bolormaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Fix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muruga","family":"Vadivale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Rousculp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young June","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2025.127496_bb0005","first-page":"162","article-title":"COVID-19 Genomics UK Consortium, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.127496_bb0010","author":"Ministry of Food and Drug Safety"},{"key":"10.1016\/j.vaccine.2025.127496_bb0015","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.127496_bb0020","author":"Reuters"},{"key":"10.1016\/j.vaccine.2025.127496_bb0025","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2025.127496_bb0030","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2025.127496_bb0035","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2025.127496_bb0045","author":"World Health Organization"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127496_bb0055","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1002\/mco2.239","article-title":"The rapid rise of SARS-CoV-2 omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants","volume":"4","author":"Ao","year":"2023","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.vaccine.2025.127496_bb0065","author":"World Health Organization"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127496_bb0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127496_bb0075","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cid\/ciac803","article-title":"Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial","volume":"76","author":"Heath","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127496_bb0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.vaccine.2025.127496_bb0085","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2025.127496_bb0090","article-title":"Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea","volume":"43","author":"Gwak","year":"2025","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127496_bb0095","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/INF.0000000000004463","article-title":"Relative effectiveness of the NVX-CoV2373 vaccine compared with the BNT162b2 vaccine in adolescents","volume":"43","author":"Lee","year":"2024","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127496_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm7304a2","volume":"73","author":"Link-Gelles","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"38","key":"10.1016\/j.vaccine.2025.127496_bb0105","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1016\/j.vaccine.2023.07.050","article-title":"Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (omicron) infection","volume":"41","author":"Liu","year":"2023","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127496_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.36854","article-title":"Estimated effectiveness of a primary cycle of protein recombinant vaccine NVX-CoV2373 against COVID-19","volume":"6","author":"Mateo-Urdiales","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127496_bb0115","article-title":"How to cope with emerging viral diseases: lessons from South Korea\u2019s strategy for COVID-19, and collateral damage to cardiometabolic health","volume":"30","author":"Lim","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2025.127496_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2023.109869","article-title":"Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023","volume":"587","author":"Kim","year":"2023","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127496_bb0125","author":"Nextstrain.org"},{"issue":"41","key":"10.1016\/j.vaccine.2025.127496_bb0130","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e314","article-title":"Effectiveness and safety of COVID-19 vaccination during Preconceptional and preclinical pregnancy period: a National Population Study","volume":"38","author":"Gwak","year":"2023","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127496_bb0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/jpm13030402","article-title":"Estimation of the effectiveness of a tighter, reinforced quarantine for the coronavirus disease 2019 (COVID-19) outbreak: analysis of the third wave in South Korea","volume":"13","author":"Park","year":"2023","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127496_bb0140","first-page":"299","article-title":"Vaccination policy and mortality from COVID-19 in the European Union","volume":"27","author":"Agostini","year":"2024","journal-title":"Econ J"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127496_bb0145","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/EDE.0000000000001484","article-title":"Use of recently vaccinated individuals to detect Bias in test-negative case-control studies of COVID-19 vaccine effectiveness","volume":"33","author":"Hitchings","year":"2022","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127496_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10650","article-title":"Evaluation of waning of SARS-CoV-2 vaccine-induced immunity: a systematic review and Meta-analysis","volume":"6","author":"Menegale","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127496_bb0155","first-page":"18","article-title":"Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial","volume":"87","author":"Liu","year":"2023","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2025.127496_bb0160","series-title":"Comparative Effectiveness of BNT162b2 and NVX-CoV2373 Vaccines in Korean Adults. medRxiv [preprint]","author":"Park","year":"2023"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127496_bb0165","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2024.02.021","article-title":"Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean adults: a population-based observational study","volume":"42","author":"Kim","year":"2024","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:28:51Z","timestamp":1766546931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25007935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"alternative-id":["S0264410X25007935"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127496","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.26.24317925","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness of NVX-CoV2373 and BNT162b2 mRNA COVID-19 vaccination in South Korea","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127496"}}